Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples